Skip to main content
. 2023 Jan 9;9:1016390. doi: 10.3389/fcvm.2022.1016390

TABLE 2.

P-Scores for the treatment regimens and outcomes.

Treatment regimen P-Score rankinga
All-cause mortality MACEs MI Stroke Stent thrombosis Major bleeding ICH
Rivaroxaban 0.969 0.949 0.360 0.960 0.317 0.591 0.621
Prasugrel 0.369 0.486 0.989 0.575 0.968 0.396 0.550
Ticagrelor60 0.632 0.648 0.405 0.622 0.382 0.224 0.347
Ticagrelor90 0.416 0.581 0.449 0.554 0.515 0.097 0.496
Clopidogrel 0.210 0.130 0.730 0.065 0.541 0.694 0.187

P-Score ranking of efficacy and safety outcomes of various dual anti-thrombotic regimens for chronic coronary syndrome.

aThe P-score represents the probability that each intervention is better than all the competing interventions, as derived from network point estimates and standard errors. MACE, major adverse cardiovascular events; MI, myocardial infarction; ICH, intracerebral hemorrhage.